INBS
Intelligent Bio Solutions Inc
$
1.610
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.940
Open
1.940
VWAP
1.66
Vol
347.75K
Mkt Cap
11.13M
Low
1.600
Amount
577.77K
EV/EBITDA(TTM)
--
Total Shares
3.12M
EV
8.50M
EV/OCF(TTM)
--
P/S(TTM)
2.35
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
3.33M
+304.22%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for Intelligent Bio Solutions Inc. (INBS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 25.78%.
Revenue Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Up
+25.78%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Intelligent Bio Solutions Inc (INBS.O) is -1.29, compared to its 5-year average forward P/E of -1.87. For a more detailed relative valuation and DCF analysis to assess Intelligent Bio Solutions Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-1.87
Current PE
-1.29
Overvalued PE
-0.17
Undervalued PE
-3.57
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
16.29
Current PS
1.13
Overvalued PS
51.84
Undervalued PS
-19.25
Financials
Annual
Quarterly
FY2025Q3
YoY :
-11.52%
728.87K
Total Revenue
FY2025Q3
YoY :
-13.56%
-2.55M
Operating Profit
FY2025Q3
YoY :
-14.60%
-2.55M
Net Income after Tax
FY2025Q3
YoY :
-69.23%
-0.44
EPS - Diluted
FY2025Q3
YoY :
+12.62%
-2.76M
Free Cash Flow
FY2025Q3
YoY :
-131.67%
5.40
Gross Profit Margin - %
FY2025Q3
YoY :
+39.06%
-354.74
FCF Margin - %
FY2025Q3
YoY :
-3.48%
-349.95
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
INBS News & Events
Events Timeline
2025-07-25 (ET)
2025-07-25
08:35:29
Intelligent Bio Solutions enters agreements to raise $3.8M in gross proceeds
2025-07-23 (ET)
2025-07-23
08:33:33
Intelligent Bio Solutions announces new data on IFDDS
2025-07-16 (ET)
2025-07-16
08:35:48
Intelligent Bio announces new global distribution agreement with SMARTOX
Sign Up For More Events
Sign Up For More Events
News
8.5
07-25NewsfilterPinnedIntelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds
9.0
07-23BenzingaEXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro Level
7.5
07-16BenzingaEXCLUSIVE: Intelligent Bio Targets Global Market With Distribution Pact For Sweat-Based Drug Detection Patch
Sign Up For More News
People Also Watch
CERO
CERo Therapeutics Holdings Inc
7.580
USD
+2.16%
BTOG
Bit Origin Ltd
0.519
USD
-0.76%
WHLR
Wheeler Real Estate Investment Trust Inc
4.100
USD
-2.84%
ONVO
Organovo Holdings Inc
0
USD
+1.47%
CEAD
CEA Industries Inc
0
USD
+23.00%
GBR
New Concept Energy Inc
0.970
USD
-0.61%
DSS
DSS Inc
1.150
USD
-1.71%
DDC
DDC Enterprise Ltd
17.780
USD
-1.28%
SSY
SunLink Health Systems Inc
1.360
USD
+11.48%
BON
Bon Natural Life Ltd
1.380
USD
-2.13%
FAQ
What is Intelligent Bio Solutions Inc (INBS) stock price today?
The current price of INBS is 1.61 USD — it has decreased -15.26 % in the last trading day.
What is Intelligent Bio Solutions Inc (INBS)'s business?
What is the price predicton of INBS Stock?
What is Intelligent Bio Solutions Inc (INBS)'s revenue for the last quarter?
What is Intelligent Bio Solutions Inc (INBS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Intelligent Bio Solutions Inc (INBS)'s fundamentals?
How many employees does Intelligent Bio Solutions Inc (INBS). have?